BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38036994)

  • 1. Risk factors for metachronous colorectal cancer and advanced neoplasia following primary colorectal cancer: a systematic review and meta-analysis.
    Zhang Y; Karahalios A; Aung YK; Win AK; Boussioutas A; Jenkins MA
    BMC Gastroenterol; 2023 Nov; 23(1):421. PubMed ID: 38036994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Metachronous Colorectal Advanced Neoplasia and Cancer in Patients With 3-4 Nonadvanced Adenomas at Index Colonoscopy: A Systematic Review and Meta-Analysis.
    Park S; Jeon SR; Kim HG; Jung Y; Kwak MS; Kim SY; Kim JW; Nam SJ; Oh EH; Park SY; Park SK; Byeon JS; Boo SJ; Baek DH; Yoon SM; Chun J; Lee J; Choi M
    Am J Gastroenterol; 2022 Apr; 117(4):588-602. PubMed ID: 35169108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for metachronous colorectal cancer or polyp: A systematic review and meta-analysis.
    Jayasekara H; Reece JC; Buchanan DD; Ahnen DJ; Parry S; Jenkins MA; Win AK
    J Gastroenterol Hepatol; 2017 Feb; 32(2):301-326. PubMed ID: 27356122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between family history of colorectal cancer and the risk of metachronous colorectal neoplasia following polypectomy in patients aged < 50 years.
    Kim NH; Jung YS; Park JH; Park DI; Sohn CI
    J Gastroenterol Hepatol; 2019 Feb; 34(2):383-389. PubMed ID: 30554426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review of Prevalence, Risk Factors, and Risk for Metachronous Advanced Neoplasia in Patients With Young-Onset Colorectal Adenoma.
    Enwerem N; Cho MY; Demb J; Earles A; Heskett KM; Liu L; Singh S; Gupta S
    Clin Gastroenterol Hepatol; 2021 Apr; 19(4):680-689.e12. PubMed ID: 32428708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Metachronous Colorectal Cancer or Advanced Adenomas After Endoscopic Resection of High-risk Adenomas.
    Baile-Maxía S; Mangas-Sanjuán C; Ladabaum U; Hassan C; Rutter MD; Bretthauer M; Medina-Prado L; Sala-Miquel N; Pomares OM; Zapater P; Jover R
    Clin Gastroenterol Hepatol; 2023 Mar; 21(3):630-643. PubMed ID: 36549471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher incidence of metachronous advanced neoplasia in patients with synchronous advanced neoplasia and left-sided colorectal resection for colorectal cancer.
    Yabuuchi Y; Imai K; Hotta K; Ito S; Kishida Y; Yamaguchi T; Shiomi A; Kinugasa Y; Yoshida M; Tanaka M; Kawata N; Kakushima N; Takizawa K; Ishiwatari H; Matsubayashi H; Ono H
    Gastrointest Endosc; 2018 Aug; 88(2):348-359.e1. PubMed ID: 29574125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study.
    Jayasekara H; Reece JC; Buchanan DD; Rosty C; Dashti SG; Ait Ouakrim D; Winship IM; Macrae FA; Boussioutas A; Giles GG; Ahnen DJ; Lowery J; Casey G; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Lindor NM; Hopper JL; Parry S; Jenkins MA; Win AK
    Int J Cancer; 2016 Sep; 139(5):1081-90. PubMed ID: 27098183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serrated Polyps and the Risk of Metachronous Colorectal Advanced Neoplasia: A Systematic Review and Meta-Analysis.
    Jung YS; Park JH; Park CH
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):31-43.e1. PubMed ID: 33007512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-Onset Colorectal Cancer Is Associated with a Lower Risk of Metachronous Advanced Neoplasia than Traditional-Onset Colorectal Cancer.
    Chen FW; Yang L; Cusumano VT; Chong MC; Lin JK; Partida D; May FP
    Dig Dis Sci; 2022 Mar; 67(3):1045-1053. PubMed ID: 33721159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients.
    Lee SY; Kim BC; Han KS; Hong CW; Sohn DK; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
    J Dig Dis; 2014 Jul; 15(7):367-76. PubMed ID: 24773758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah.
    Samadder NJ; Curtin K; Wong J; Tuohy TM; Mineau GP; Smith KR; Pimentel R; Pappas L; Boucher K; Garrido-Laguna I; Provenzale D; Burt RW
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2078-84.e1-2. PubMed ID: 24768809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using New Hampshire Colonoscopy Registry data to assess United States and European post-polypectomy surveillance guidelines.
    Liu MC; Anderson JC; Hisey W; MacKenzie TA; Robinson CM; Butterly LF
    Endoscopy; 2023 May; 55(5):423-431. PubMed ID: 36316016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of adenomatous polyposis in a fecal immunochemical test-based colorectal cancer screening program and risk of advanced neoplasia during follow-up.
    Carballal S; Sánchez A; Moreira L; Cuellar-Monterrubio JE; Bernuy J; Daca M; Ortiz O; Ocaña T; Rivero-Sánchez L; Jung G; Serradesanferm A; Pozo A; Grau J; Torá I; Zaffalon D; Castells A; Pellisé M; Balaguer F;
    Endoscopy; 2022 Jul; 54(7):688-697. PubMed ID: 34607378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced synchronous adenoma but not simple adenoma predicts the future development of metachronous neoplasia in patients with resected colorectal cancer.
    Moon CM; Cheon JH; Choi EH; Kim ES; Park JJ; Han SY; Kim DH; Kim TI; Kim WH
    J Clin Gastroenterol; 2010 Aug; 44(7):495-501. PubMed ID: 20351568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Risk of Metachronous Advanced Colorectal Neoplasia Rises in Parallel with an Increasing Number of High-Risk Findings at Baseline.
    Lee SM; Kim JH; Sung IK; Hong SN
    Gut Liver; 2015 Nov; 9(6):741-9. PubMed ID: 25963078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selenium for preventing cancer.
    Vinceti M; Filippini T; Del Giovane C; Dennert G; Zwahlen M; Brinkman M; Zeegers MP; Horneber M; D'Amico R; Crespi CM
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD005195. PubMed ID: 29376219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metachronous advanced neoplasia after submucosal invasive colorectal cancer resection.
    Minamide T; Ikematsu H; Murano T; Kadota T; Shinmura K; Yoda Y; Hori K; Ito M; Yano T
    Sci Rep; 2021 Jan; 11(1):1869. PubMed ID: 33479474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.